Cargando…
Dual Effect of Ziconotide in Primary Erythromelalgia
Erythromelalgia (EM) is a rare disabling clinical syndrome more commonly known to affect the lower extremities. There is no single effective treatment for this disease that often requires a multidisciplinary approach. Herein, we report the case of a 31-year-old woman affected by primary erythromelal...
Autores principales: | Russo, Rosario, Caroleo, Maria Cristina, Cione, Erika, Perri, Mariarita, Paparo, Maria Teresa, Russo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644814/ https://www.ncbi.nlm.nih.gov/pubmed/26609309 http://dx.doi.org/10.1155/2015/592170 |
Ejemplares similares
-
Investigation of TNBC in vitro Antiproliferative Effects of Versatile Pirrolo[1,2-a]quinoxaline Compounds
por: Perri, Mariarita, et al.
Publicado: (2019) -
Pneumonia, lung cancer or Medlar's core?
por: Luciani, Filippo, et al.
Publicado: (2015) -
Sympathetic Block for Treating Primary Erythromelalgia
por: Bang, Yoo Jin, et al.
Publicado: (2010) -
Experience with oral mexiletine in primary erythromelalgia in children
por: Iqbal, Javeed, et al.
Publicado: (2009) -
Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases
por: Grajny, Kristopher, et al.
Publicado: (2020)